Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease
Author(s) -
Emerson C. Perin,
Michael P. Murphy,
Keith L. March,
Roberto Bolli,
John Loughran,
Phillip C. Yang,
Nicholas J. Leeper,
Ronald L. Dalman,
Jason Alexander,
Timothy D. Henry,
Jay H. Traverse,
Carl J. Pepine,
R. David Anderson,
Scott A. Berceli,
James T. Willerson,
Raja Muthupillai,
Amir Gahremanpour,
Ganesh Raveendran,
Omaida Velasquez,
Joshua M. Hare,
Ivonne Hernandez Schulman,
Vijaykumar S. Kasi,
William R. Hiatt,
Bharath AmbaleVenkatesh,
João A.C. Lima,
Doris A. Taylor,
Micheline Resende,
Adrian P. Gee,
April Durett,
Jeanette Bloom,
Sara Richman,
Patricia G’Sell,
Shari Williams,
Fouzia Khan,
Elsie Gyang Ross,
Michelle Santoso,
JoAnne Goldman,
Dana Leach,
Eileen Handberg,
Benjamin Cheong,
Nichole Piece,
Darcy L. DiFede,
Barb Bruhn-Ding,
Emily Caldwell,
Judy Bettencourt,
Dejian Lai,
Linda B. Piller,
Lara M. Simpson,
Michelle Cohen,
Shelly L. Sayre,
Rachel W. Vojvodic,
Lem Moyé,
Ray F. Ebert,
Robert D. Simari,
Alan T. Hirsch
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.025707
Subject(s) - medicine , peripheral , arterial disease , perfusion , cardiology , disease , vascular disease , physical therapy
Atherosclerotic peripheral artery disease affects 8% to 12% of Americans >65 years of age and is associated with a major decline in functional status, increased myocardial infarction and stroke rates, and increased risk of ischemic amputation. Current treatment strategies for claudication have limitations. PACE (Patients With Intermittent Claudication Injected With ALDH Bright Cells) is a National Heart, Lung, and Blood Institute-sponsored, randomized, double-blind, placebo-controlled, phase 2 exploratory clinical trial designed to assess the safety and efficacy of autologous bone marrow-derived aldehyde dehydrogenase bright (ALDHbr) cells in patients with peripheral artery disease and to explore associated claudication physiological mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom